ターゲットシーケンス市場：製品タイプ、用途、エンドユーザー別-2025-2030年の世界予測

ターゲットシーケンス市場は、2023年に62億3,000万米ドルと評価され、2024年には76億米ドルに達すると予測され、CAGR 20.30%で成長し、2030年には227億3,000万米ドルに達すると予測されています。

ターゲットシーケンスは、遺伝子配列全体ではなく、ゲノムの特定領域を解析するために使用される技術であり、特定の疾患や状態に関連する関心領域に焦点を当てることで、時間効率とコスト効率の両方を実現します。その必要性は、遺伝子変異に関する包括的な洞察を提供し、個別化医療、がん研究、希少疾患診断の進歩を促進する能力に由来します。開発用途は臨床診断、医薬品開発、アグリゲノミクス、分子生物学研究など多岐にわたり、最終用途はヘルスケア、バイオテクノロジー、農業の各分野に及ぶ。同市場は、シーケンシング手法の技術的進歩、遺伝子研究資金の増加、遺伝性疾患の有病率の増加といった要因によって支えられています。個別化医療やコンパニオン診断の需要が高まるにつれ、ターゲットシーケンスの採用は増加すると予想されます。最近のビジネスチャンスは、バイオインフォマティクスツールの進歩やシーケンス技術のコスト低下から生じています。企業は、効率と精度を高める革新的な技術に投資し、遺伝子研究が勢いを増す新興市場にサービスを拡大することで、これらを活用することができます。

しかし、市場成長は、高い初期費用、複雑な規制承認プロセス、データ解釈の課題などの限界に直面しています。さらに、データ解析のための熟練した専門家の不足や、遺伝子のプライバシーをめぐる倫理的な議論がハードルとなる可能性もあります。これらを克服するために、企業はユーザーフレンドリーで自動化されたプラットフォームの開発に注力し、人材育成のための教育機関との連携を促進すべきです。

イノベーションの機会は、シーケンスの精度とスピードの向上、より良いデータ分析のためのAIの統合、動物学や人類学のような他の分野でのターゲットシーケンスの新しいアプリケーションの探求にあります。市場のペースが速く、技術の進歩に大きく依存するという市場の性質を考慮すると、このダイナミックな分野で競争力を維持するために、業界の利害関係者は研究パートナーシップと継続的開発を重視すべきです。

市場力学：急速に進化するターゲットシーケンス市場の主要市場インサイトを公開

ターゲットシーケンス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 迅速な結果と高い精度による、臨床診断におけるターゲットシーケンス技術の広範な採用
  • 植物の遺伝的可能性を分析する農業分野での採用が増加
  • 精密医薬品へのターゲットシーケンス応用の増加
• 市場抑制要因
  • 臨床データを分析・解釈するための計算リソースとスタッフの不足
• 市場機会
  • ターゲットシーケンスの新技術開発への継続的な注力
  • 大規模シーケンス技術に対する政府および民間企業からの支援の増加
• 市場の課題
  • ターゲットシーケンスデータ保護に関する倫理的・プライバシー的懸念

ポーターのファイブフォース：ターゲットシーケンス市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、ターゲットシーケンス市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ターゲットシーケンス市場における外部からの影響の把握

外部マクロ環境要因は、ターゲットシーケンス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ターゲットシーケンス市場における競合情勢の把握

ターゲットシーケンス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスターゲットシーケンス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ターゲットシーケンス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ターゲットシーケンス市場における成功への道筋を描く

ターゲットシーケンス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 結果が早く、精度が高いため、臨床診断においてターゲットシーケンステクノロジーが広く採用されている
    • 植物の遺伝的可能性を分析するために農業分野で採用が拡大
    • 精密医療におけるターゲットシーケンスの適用拡大
  • 抑制要因
    • 臨床データを分析・解釈するための計算リソースと人員の不足
  • 機会
    • 新しい技術開発への継続的な注力新規なターゲットシーケンス技術
    • 大規模シーケンシング技術に対する政府と民間部門からの支援の強化
  • 課題
    • ターゲットシーケンスデータ保護に関する倫理的およびプライバシー上の懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ターゲットシーケンス市場：製品タイプ別

• 消耗品
• プラットフォーム
• サービス

第7章 ターゲットシーケンス市場：用途別

• 心血管疾患
• 遺伝性疾患
• 感染症
• 神経疾患
• 腫瘍学
• 生殖に関する健康

第8章 ターゲットシーケンス市場：エンドユーザー別

• 学術調査機関
• 臨床検査室
• 契約調査機関
• 製薬・バイオテクノロジー企業

第9章 南北アメリカのターゲットシーケンス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のターゲットシーケンス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのターゲットシーケンス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 10x Genomics, Inc.
• A-Alpha Bio, Inc.
• Agilent Technologies, Inc.
• Azenta Life Sciences
• BGI Genomics Co., Ltd.
• Bio-Rad Laboratories, Inc.
• CD Genomics
• DH Life Sciences, LLC
• Element Biosciences
• F. Hoffmann-La Roche Ltd.
• Illumina, Inc.
• LGC Limited
• Macrogen, Inc.
• MGI Tech Co., Ltd.
• Oxford Nanopore Technologies PLC
• Pacific Biosciences of California, Inc.
• Paragon Genomics, Inc.
• PerkinElmer, Inc.
• Psomagen, Inc.
• QIAGEN N.V.
• Singular Genomics Systems, Inc.
• Takara Bio Inc.
• Tecan Trading AG
• Thermo Fisher Scientific Inc.
• Twist Bioscience Corporation

LIST OF FIGURES

• FIGURE 1. TARGETED SEQUENCING MARKET RESEARCH PROCESS
• FIGURE 2. TARGETED SEQUENCING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL TARGETED SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. TARGETED SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. TARGETED SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. TARGETED SEQUENCING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL TARGETED SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. TARGETED SEQUENCING MARKET DYNAMICS
• TABLE 7. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HEREDITARY DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REPRODUCTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. CANADA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CANADA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. CANADA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. CHINA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 51. CHINA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. CHINA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. INDIA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDIA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. INDIA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. ITALY TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 106. ITALY TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. ITALY TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. POLAND TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 118. POLAND TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. POLAND TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. QATAR TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 121. QATAR TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. QATAR TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. TARGETED SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 151. TARGETED SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023

The Targeted Sequencing Market was valued at USD 6.23 billion in 2023, expected to reach USD 7.60 billion in 2024, and is projected to grow at a CAGR of 20.30%, to USD 22.73 billion by 2030.

Targeted sequencing is a technique used to analyze specific areas of the genome rather than the entire genetic sequence, making it both time-efficient and cost-effective by focusing on regions of interest that are pertinent to particular diseases or conditions. Its necessity stems from its ability to provide comprehensive insights into genetic mutations, facilitating advancements in personalized medicine, cancer research, and rare disease diagnosis. Applications extend into clinical diagnosis, drug development, agrigenomics, and molecular biology research, with end-use across healthcare, biotechnology, and agricultural sectors. The market is buoyed by factors such as technological advancements in sequencing methods, increased genetic research funding, and the growing prevalence of genetic disorders. Adoption of targeted sequencing is expected to rise as the demand for personalized medicine and companion diagnostics increases. Recent opportunities arise from advancements in bioinformatics tools and the decreasing cost of sequencing technologies. Companies can capitalize on these by investing in innovative technologies that increase efficiency and accuracy, as well as expanding their services to emerging markets where genetic research is gaining momentum.

However, market growth faces limitations such as high initial costs, complex regulatory approval processes, and data interpretation challenges. Additionally, a lack of skilled professionals for data analysis and an ethical debate surrounding genetic privacy may pose hurdles. To overcome these, businesses should focus on developing user-friendly, automated platforms and foster collaborations with educational institutions for workforce training.

Innovation opportunities lie in enhancing sequencing accuracy and speed, integrating AI for better data analysis, and exploring new applications of targeted sequencing in other fields like zoology and anthropology. Considering the market's nature, which is fast-paced and heavily reliant on technological advances, industry stakeholders should emphasize research partnerships and continuous development to maintain a competitive edge in this dynamic sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Targeted Sequencing Market

The Targeted Sequencing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Extensive adoption of targeted sequencing technologies in clinical diagnostics due to rapid result time and higher accuracy
  • Emerging adoption in the agriculture sector to analyze the genetic potential of plants
  • Increased application of targeted sequencing for precision medicines
• Market Restraints
  • Lack of the computational resources and staffing to analyze and interpret clinical data
• Market Opportunities
  • Continuous focus on new technology development novel targeted sequencing technologies
  • Increased support from government and private sector for large scale sequencing technology
• Market Challenges
  • Ethical and privacy concerns related to targeted sequencing data protection

Porter's Five Forces: A Strategic Tool for Navigating the Targeted Sequencing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Targeted Sequencing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Targeted Sequencing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Targeted Sequencing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Targeted Sequencing Market

A detailed market share analysis in the Targeted Sequencing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Targeted Sequencing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Targeted Sequencing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Targeted Sequencing Market

A strategic analysis of the Targeted Sequencing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Targeted Sequencing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., A-Alpha Bio, Inc., Agilent Technologies, Inc., Azenta Life Sciences, BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., CD Genomics, DH Life Sciences, LLC, Element Biosciences, F. Hoffmann-La Roche Ltd., Illumina, Inc., LGC Limited, Macrogen, Inc., MGI Tech Co., Ltd., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., Paragon Genomics, Inc., PerkinElmer, Inc., Psomagen, Inc., QIAGEN N.V., Singular Genomics Systems, Inc., Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., and Twist Bioscience Corporation.

Market Segmentation & Coverage

This research report categorizes the Targeted Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Consumables, Platforms, and Services.
• Based on Application, market is studied across Cardiovascular Diseases, Hereditary Diseases, Infectious Diseases, Neurological Disorders, Oncology, and Reproductive Health.
• Based on End-User, market is studied across Academic & Research Institutes, Clinical Laboratories, Contract Research Organization, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Extensive adoption of targeted sequencing technologies in clinical diagnostics due to rapid result time and higher accuracy
    • 5.1.1.2. Emerging adoption in the agriculture sector to analyze the genetic potential of plants
    • 5.1.1.3. Increased application of targeted sequencing for precision medicines
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of the computational resources and staffing to analyze and interpret clinical data
  • 5.1.3. Opportunities
    • 5.1.3.1. Continuous focus on new technology development novel targeted sequencing technologies
    • 5.1.3.2. Increased support from government and private sector for large scale sequencing technology
  • 5.1.4. Challenges
    • 5.1.4.1. Ethical and privacy concerns related to targeted sequencing data protection
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Targeted Sequencing Market, by Product Type

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Platforms
• 6.4. Services

7. Targeted Sequencing Market, by Application

• 7.1. Introduction
• 7.2. Cardiovascular Diseases
• 7.3. Hereditary Diseases
• 7.4. Infectious Diseases
• 7.5. Neurological Disorders
• 7.6. Oncology
• 7.7. Reproductive Health

8. Targeted Sequencing Market, by End-User

• 8.1. Introduction
• 8.2. Academic & Research Institutes
• 8.3. Clinical Laboratories
• 8.4. Contract Research Organization
• 8.5. Pharmaceutical & Biotechnology Companies

9. Americas Targeted Sequencing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Targeted Sequencing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Targeted Sequencing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 10x Genomics, Inc.
• 2. A-Alpha Bio, Inc.
• 3. Agilent Technologies, Inc.
• 4. Azenta Life Sciences
• 5. BGI Genomics Co., Ltd.
• 6. Bio-Rad Laboratories, Inc.
• 7. CD Genomics
• 8. DH Life Sciences, LLC
• 9. Element Biosciences
• 10. F. Hoffmann-La Roche Ltd.
• 11. Illumina, Inc.
• 12. LGC Limited
• 13. Macrogen, Inc.
• 14. MGI Tech Co., Ltd.
• 15. Oxford Nanopore Technologies PLC
• 16. Pacific Biosciences of California, Inc.
• 17. Paragon Genomics, Inc.
• 18. PerkinElmer, Inc.
• 19. Psomagen, Inc.
• 20. QIAGEN N.V.
• 21. Singular Genomics Systems, Inc.
• 22. Takara Bio Inc.
• 23. Tecan Trading AG
• 24. Thermo Fisher Scientific Inc.
• 25. Twist Bioscience Corporation